Lupin Celebrates Debut In S&P Global Sustainability Yearbook 2024 With Impressive ESG Score

Lupin, a global pharmaceutical company in a press statement on Friday announced its inaugural presence in the prestigious S&P Global Sustainability Yearbook 2024, emphasising its unwavering commitment to corporate sustainability. The company secured a commendable Corporate Sustainability Assessment (CSA) score of 69/100, placing it among the distinguished group of 739 companies globally recognised for their exceptional environmental, social, and governance (ESG) practices.

The S&P Global Sustainability Yearbook 2024, serving as a benchmark for corporate sustainability performance, rigorously assessed more than 9400 companies worldwide. Lupin's outstanding performance positions it within the top 95 percentile in the pharmaceutical sector.

Ramesh Swaminathan, Executive Director, Global CFO, and Head of Corporate Affairs at Lupin, expressed his thoughts on this achievement, stating, "Lupin’s inclusion in the S and P Global Sustainability Yearbook 2024 underscores our firm commitment to advancing sustainable practices within the pharmaceutical industry. This recognition reaffirms our dedication to creating long-term value for all stakeholders while fostering a healthier, more sustainable future for generations to come."